Company Updates
Company Updates
Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board
Company Updates
Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round
Company Updates
Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors
Company Updates
Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board
Breath Biopsy
Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation
Breath Biopsy
Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD
Breath Biopsy
Owlstone Medical launches Breath Biopsy Kits
Company Updates
Owlstone Medical raises $15 million USD (£11 million GBP) with Horizons Ventures and Aviva
Breath Biopsy
Owlstone Medical’s Breath Biopsy Wins Global IPF Catalyst Challenge
Breath Biopsy
The Economist: Follow Your Nose
Breath Biopsy
Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial
